Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi-Aventis diabetes drug meets study endpoints
Sanofi-Aventis diabetes drug meets study endpoints
Sanofi-Aventis diabetes drug meets study endpoints
Submitted by
admin
on April 15, 2010 - 8:43am
Source:
Marketwatch
News Tags:
diabetes
Sanofi
lixisenatide
Headline:
Sanofi-Aventis diabetes drug meets study endpoints
Do Not Allow Advertisers to Use My Personal information
